1. |
Scope |
1.1. |
Definition of Decontamination |
1.2. |
Scope of This Report |
1.3. |
Basic Assumptions |
1.3.1. |
General |
1.3.2. |
Stockpiling Decontamination Means |
1.3.3. |
Possible Scenario Analysis |
1.4. |
Methodology |
1.4.1. |
Research Methods |
1.4.2. |
Report Structure |
1.5. |
Who is This Report For? |
2. |
Executive Summary |
2.1. |
Main Conclusions |
2.2. |
CBRN Terrorism |
2.3. |
Post event CBRN & HAZMAT Decontaminating Process |
2.4. |
The Decontamination Industry |
2.5. |
Decontamination Market |
2.6. |
Technological Challenges |
2.7. |
Federal HLS Decontamination R&D Funding |
3. |
Decontamination Market Drivers |
4. |
Decontamination Market Inhibitors |
5. |
The Obama Administration CBRN Terror Mitigation Strategy |
6. |
Decontamination: Technological Requirements |
6.1. |
The Problem |
6.2. |
The Decontamination Process |
6.2.1. |
Contaminant Identification |
6.2.2. |
Sample Characterization |
6.2.3. |
Isolation of Contaminated Area |
6.2.4. |
Design of Decontamination Strategy |
6.2.5. |
Decontamination |
6.2.6. |
Clearance Sampling |
6.3. |
Building & People Decontamination |
6.3.1. |
People Decontamination |
6.3.2. |
Buildings Decontamination |
6.4. |
Performance Challenges |
6.4.1. |
Challenge 1 |
6.4.2. |
Challenge 2 |
6.4.3. |
Challenge 3 |
6.4.4. |
Challenge 4 |
6.4.5. |
Challenge 5 |
6.4.6. |
Challenge 6 |
6.4.7. |
Challenge 7 |
6.5. |
Technologies Overview |
6.6. |
Physics-Based Decontamination Core Technologies |
6.6.1. |
Sorbents |
6.6.2. |
Solvent-Wash |
6.6.3. |
High-Pressure Methods |
6.6.4. |
Thermal Methods |
6.7. |
Chemistry-Based Decontamination Core Technologies |
6.7.1. |
Oxidizing Agents |
6.7.2. |
Strong Bases |
6.7.3. |
Surfactants |
6.7.4. |
Microemulsions |
6.8. |
Biology-Based Technologies |
6.8.1. |
Bacterial Decontamination Agents |
6.8.2. |
Enzymatic Systems |
6.9. |
Decontamination System Configurations |
6.9.1. |
Application 1 People Decontamination Systems |
6.9.2. |
Application 2 Equipment Decontamination Systems |
6.10. |
Indoor Heavy Equipment Decontamination |
6.10.1. |
Application 3 Building and Infrastructure Decontamination Systems |
6.11. |
New Technologies Drivers |
6.12. |
New Technologies Inhibitors |
7. |
Decontamination Equipment Market Outlook 2010 2014 |
7.1. |
Scope, Assumptions and Overview |
7.2. |
U.S. Incidents Decontamination Equipment Sales & Service Outlook 2010 2014 |
7.3. |
Decontamination Equipment Market Forecast 2010 2014 |
7.4. |
Decontamination Equipment Service & Upgrade Market 2010 2014 |
8. |
Business Opportunities 2010-2014 |
8.1. |
Historical Perspective: A Market Waiting for Transition |
8.1.1. |
HLS Decontamination Strategy Outlook |
8.1.2. |
Factors Affecting Decontamination Systems Business Opportunities |
8.2. |
Business Opportunities for Decontamination Systems |
8.2.1. |
Business Opportunity 1 |
8.2.2. |
Business Opportunity 2 |
8.2.3. |
Business Opportunity 3 |
8.2.4. |
Business Opportunity 4 |
8.2.5. |
Business Opportunity 5 |
8.2.6. |
Business Opportunity 6 |
8.2.7. |
Business Opportunity 7 |
8.3. |
Radiological Decontamination Technologies |
8.3.1. |
Business Opportunity 8 |
8.3.2. |
Business Opportunity 9 |
8.3.3. |
Business Opportunity 10 |
8.3.4. |
Business Opportunity 11 |
8.3.5. |
Business Opportunity 12 |
8.4. |
Chemical-Biological Decontamination Technologies and Business Opportunities |
8.4.1. |
Business Opportunity 13 |
8.4.2. |
Business Opportunity 14 |
8.4.3. |
Business Opportunity 15 |
8.4.4. |
Business Opportunity 16 |
8.4.5. |
Business Opportunity 17 |
8.4.6. |
Business Opportunity 18 |
8.4.7. |
Business Opportunity 19 |
8.4.8. |
Business Opportunity 20 |
8.4.9. |
Business Opportunity 21 |
8.5. |
Contamination Simulation Algorithms |
8.5.1. |
Business Opportunity 22 |
9. |
Decontamination Federal HLS R&D Programs and Funding Opportunities Forecast 2010-2014 |
9.1. |
Summary & Outlook |
9.2. |
Decontamination Federal HLS R&D Funding Opportunities by Major Departments Forecast 2010-2014 |
9.2.1. |
EPA Decontamination R&D |
9.2.2. |
DOD Decontamination HLS R&D |
9.2.3. |
DHS Decontamination HLS R&D |
9.2.4. |
DOE Decontamination R&D |
9.2.5. |
TSWG Decontamination R&D |
9.3. |
Decontamination Federal HLS R&D Funding Opportunities Forecast 2010-2014 |
9.4. |
Decontamination Federal HLS R&D Funding Opportunities Drivers |
9.5. |
Decontamination Federal HLS R&D Funding Opportunities Inhibitors |
9.6. |
DHS Decontamination HLS R&D Programs |
9.6.1. |
Response and Recovery |
9.6.2. |
Decontamination of Porous Surfaces after a Radiological Attack |
9.6.3. |
Expedient Mitigation of a Radiological Release |
9.7. |
DARPA (DOD) Decontamination HLS R&D Programs |
9.7.1. |
Immune Buildings |
9.7.2. |
External Protection |
9.8. |
CBDP (DOD) Decontamination HLS R&D Programs |
9.8.1. |
Project CB1 Decontamination |
9.8.2. |
Project CB2 Decontamination |
9.8.3. |
Project CB3 Biological Defense (ATD) Decontamination |
9.9. |
ARMY (DOD) Decontamination HLS R&D Programs |
9.9.1. |
Environmental Quality Technology |
9.10. |
DOE Decontamination HLS R&D Programs |
9.10.1. |
Environmental Remediation Science Research |
9.11. |
EPA Decontamination HLS R&D Programs |
9.11.1. |
Water Infrastructure Decontamination |
9.11.2. |
Threat and Consequence Assessment |
9.11.3. |
Nonstandard Methods |
9.11.4. |
Decontamination for Buildings, Large Structures, and Outdoor Areas |
9.11.5. |
Toxicity, Infectivity, and Mechanism of Action |
9.12. |
TSWG Decontamination HLS R&D Programs |
9.12.1. |
Statistical Design Tool for Sampling Contaminated Buildings |
9.12.2. |
Decontamination |
10. |
Vendors and Products |
10.1. |
Decontamination systems- Vendors and Products |
10.2. |
Other Decontamination Equipment, Kits etc |
11. |
Guidelines for Equipment Procurement |
11.1. |
Equipment Selection Factors |
11.2. |
Equipment Evaluation |
11.2.1. |
Commercial Decontaminants |
11.2.2. |
Decontamination Delivery Systems (Liquids) |
11.2.3. |
Decontamination Delivery Systems (Gaseous) |
11.2.4. |
Decontamination Shower Systems |
11.2.5. |
Decontamination Shower Hardware |
11.2.6. |
Decontamination Kits |
11.2.7. |
Decontamination Containment Items |
11.2.8. |
Decontamination Support Equipment |
12. |
Appendix A: CBRN Terror |
12.1. |
Biological Terror |
12.1.1. |
Bio-Weapons Historical Perspective |
12.1.2. |
Biological Terror Bacterial Agents |
12.1.3. |
Biological Terror Viral Agents |
12.1.4. |
Biological Terror Rickettsiae Agents |
12.1.5. |
Biological Terror Toxins |
12.2. |
Nuclear-Radiological Terror |
12.2.1. |
How Real is the Nuclear Threat? |
12.2.2. |
Nuclear Terror |
12.2.3. |
Radiological Dispersal Devices (RDD) |
12.3. |
Chemical Terror |
12.3.1. |
Nerve Agents |
12.3.2. |
Blister Agents |
13. |
Appendix B: Patent Review |
13.1. |
Scope |
13.2. |
Decontamination Technology Patents |
14. |
Appendix C – Decontamination Legal Issues |
14.1. |
International Legislation/Agreements |
14.1.1. |
The Nuclear Weapons Non-Proliferation Treaty (NPT) 1970 |
14.1.2. |
The Biological and Toxin Weapons Convention (BTWC) 1972 |
14.1.3. |
Convention for the Physical Protection of Nuclear Material 1987 |
14.1.4. |
Chemicals Weapons Convention 1992 |
14.2. |
U.S. Legislation |
14.2.1. |
U.S. Code Title 50, Chapter 40 Defense Against Weapons of Mass Destruction |
14.2.2. |
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1996 |
14.2.3. |
Emergency Supplemental Appropriations Act for Recovery from and Response to Terrorist Attacks on the United States 2001 |
14.2.4. |
Public Health Security and Bioterrorism Preparedness and Response Act 2002 |
14.2.5. |
Pandemic and All-Hazards Preparedness Act (PAHPA), 2006 |
14.2.6. |
Homeland Security Presidential Directive 21 |